ThermoGenesis Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for ThermoGenesis Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
It's Down 52% But ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Could Be Riskier Than It Looks
Apr 17ThermoGenesis reports Q2 results
Aug 11Is ThermoGenesis Holdings (NASDAQ:THMO) Using Too Much Debt?
Oct 20Is ThermoGenesis Holdings (NASDAQ:THMO) A Risky Investment?
May 31When Will ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Become Profitable?
Apr 06Here's Why ThermoGenesis Holdings (NASDAQ:THMO) Can Afford Some Debt
Feb 10Does ThermoGenesis Holdings' (NASDAQ:THMO) CEO Salary Compare Well With Industry Peers?
Dec 15ThermoGenesis EPS misses by $0.27, misses on revenue
Nov 12In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ThermoGenesis Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | 10 | -15 | -5 | -4 | N/A |
12/31/2023 | 9 | -18 | -5 | -4 | N/A |
9/30/2023 | 10 | -14 | -4 | -3 | N/A |
6/30/2023 | 10 | -14 | -5 | -4 | N/A |
3/31/2023 | 10 | -14 | -5 | -4 | N/A |
12/31/2022 | 10 | -11 | -8 | -7 | N/A |
9/30/2022 | 10 | -10 | -7 | -6 | N/A |
6/30/2022 | 11 | -9 | -7 | -6 | N/A |
3/31/2022 | 10 | -11 | -7 | -7 | N/A |
12/31/2021 | 9 | -11 | -7 | -7 | N/A |
9/30/2021 | 9 | -12 | -9 | -9 | N/A |
6/30/2021 | 8 | -12 | -11 | -11 | N/A |
3/31/2021 | 8 | -14 | -16 | -16 | N/A |
12/31/2020 | 10 | -16 | -14 | -14 | N/A |
9/30/2020 | 10 | -18 | -12 | -12 | N/A |
6/30/2020 | 11 | -17 | -9 | -9 | N/A |
3/31/2020 | 13 | -12 | -4 | -3 | N/A |
12/31/2019 | 13 | -9 | -3 | -3 | N/A |
9/30/2019 | 14 | -13 | -4 | -3 | N/A |
6/30/2019 | 13 | -13 | -4 | -4 | N/A |
3/31/2019 | 11 | -39 | -8 | -7 | N/A |
12/31/2018 | 10 | -40 | -8 | -7 | N/A |
9/30/2018 | 10 | -32 | -10 | -9 | N/A |
6/30/2018 | 10 | -32 | -11 | -9 | N/A |
3/31/2018 | 11 | -6 | -8 | -7 | N/A |
12/31/2017 | 13 | -6 | N/A | -8 | N/A |
9/30/2017 | 14 | -9 | N/A | -7 | N/A |
6/30/2017 | 15 | -29 | N/A | -7 | N/A |
3/31/2017 | 14 | -32 | N/A | -6 | N/A |
12/31/2016 | 14 | -40 | N/A | -8 | N/A |
9/30/2016 | 13 | -38 | N/A | -10 | N/A |
6/30/2016 | 12 | -19 | N/A | -10 | N/A |
3/31/2016 | 13 | -17 | N/A | -10 | N/A |
12/31/2015 | 14 | -11 | N/A | -9 | N/A |
9/30/2015 | 15 | -15 | N/A | -8 | N/A |
6/30/2015 | 16 | -15 | N/A | -11 | N/A |
3/31/2015 | 16 | -15 | N/A | -11 | N/A |
12/31/2014 | 16 | -12 | N/A | -9 | N/A |
9/30/2014 | 16 | -10 | N/A | -10 | N/A |
6/30/2014 | 16 | -9 | N/A | -8 | N/A |
3/31/2014 | 16 | -8 | N/A | -7 | N/A |
12/31/2013 | 17 | -7 | N/A | -5 | N/A |
9/30/2013 | 17 | -6 | N/A | -4 | N/A |
6/30/2013 | 18 | -3 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if THMO's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if THMO's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if THMO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if THMO's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if THMO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if THMO's Return on Equity is forecast to be high in 3 years time